Global Information
회사소개 | 문의 | 비교리스트

세계의 인간 재조합 DNA 시장

Human Recombinant DNA: Global Markets

리서치사 BCC Research
발행일 2022년 07월 상품코드 1105254
페이지 정보 영문 84 Pages 배송안내
가격
US $ 5,500 ₩ 7,207,000 PDF & Excel (Single User License)
US $ 6,600 ₩ 8,649,000 PDF & Excel (2-5 Users)
US $ 7,920 ₩ 10,379,000 PDF & Excel (Site License)
US $ 9,504 ₩ 12,454,000 PDF & Excel (Enterprise License)


세계의 인간 재조합 DNA 시장 Human Recombinant DNA: Global Markets
발행일 : 2022년 07월 페이지 정보 : 영문 84 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 인간 재조합 DNA 시장 규모는 2022년까지 3,487억 달러에 달할 것으로 보입니다.

시장은 2022-2027년 예측기간 중 7.3%의 CAGR로 확대되고, 2027년에는 4,969억 달러를 넘어설 것으로 예측됩니다.

세계의 인간 재조합 DNA(Human Recombinant DNA) 시장에 대해 조사했으며, 시장 개요와 함께 제품 종류별, 최종사용자별, 지역별 동향, COVID-19의 영향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 서론

제2장 정리와 하이라이트

제3장 개요

제4장 COVID-19 팬데믹의 영향

제5장 시장 역학

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회

제6장 시장 내역, 제품 종류별

  • 인간 단백질 치환
  • 인간 질환을 위한 치료제
  • 백신
  • 백신 종류

제7장 시장 내역, 최종사용자별

  • 바이오테크놀러지 업계, 제약 산업
  • 학술연구기관

제8장 시장 내역, 지역별

  • 지역별 세계 시장
  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제9장 경쟁 상황

제10장 기업 개요

  • ABBVIE INC.
  • ALEXION PHARMACEUTICALS
  • AMGEN INC.
  • ELI LILLY
  • MERCK & CO. INC.
  • SANOFI S.A.
  • TAKEDA PHARMACEUTICAL CO LTD.
KSM 22.08.05

List of Tables

  • Summary Table : Global Market for Human Recombinant DNA, by Region, Through 2027
  • Table 1 : Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
  • Table 2 : Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
  • Table 3 : Global Human Recombinant DNA Market, by Product Type, Through 2027
  • Table 4 : Global Market for Human Protein Replacements, by Region, Through 2027
  • Table 5 : Global Market for Therapeutic Agents for Human Diseases, by Region, Through 2027
  • Table 6 : Vaccine Types
  • Table 7 : Global Market for Vaccines, by Region, Through 2027
  • Table 8 : Global Market for Human Recombinant DNA, by End User, Through 2027
  • Table 9 : Global Market for Human Recombinant DNA in the Biotechnology and Pharmaceutical Industry, by Region, Through 2027
  • Table 10 : Global Market for Human Recombinant DNA in Research Laboratories and Academic Institutes, by Region, Through 2027
  • Table 11 : Global Market for Human Recombinant DNA, by Region, Through 2027
  • Table 12 : North American Market for Human Recombinant DNA, by Product Type Through 2027
  • Table 13 : North American Market for Human Recombinant DNA, by End User, Through 2027
  • Table 14 : North American Market for Human Recombinant DNA, by Country, Through 2027
  • Table 15 : European Market for Human Recombinant DNA, by Product Type, Through 2027
  • Table 16 : European Human Recombinant DNA Market, by End User, Through 2027
  • Table 17 : European Market for Human Recombinant DNA, by Country, Through 2027
  • Table 18 : Asia-Pacific Market for Human Recombinant DNA, by Product Type, Through 2027
  • Table 19 : Asia-Pacific Human Recombinant DNA Market, by End User, Through 2027
  • Table 20 : Asia-Pacific Market for Human Recombinant DNA, by Country, Through 2027
  • Table 21 : Japan: Total Number of New Cancer Cases in Both Genders, 2020
  • Table 22 : RoW Market for Human Recombinant DNA, by Product Type, Through 2027
  • Table 23 : RoW Market for Human Recombinant DNA, by End User, Through 2027
  • Table 24 : Leading Market Players in the Human Recombinant DNA Market Ecosystem
  • Table 25 : AbbVie Inc.: Business Segments
  • Table 26 : AbbVie Inc.: Financial Performance, Through 2020
  • Table 27 : Amgen: Financial Performance, Through 2020
  • Table 28 : Eli Lilly: Business Segments
  • Table 29 : Eli Lilly: Financial Performance, 2018-2020
  • Table 30 : Sanofi: Business Segments
  • Table 31 : Sanofi: Financial Performance, 2018-2020

List of Figures

  • Summary Figure A : Global Market for Human Recombinant DNA, by Region, 2020-2027
  • Summary Figure B : Global Market Shares of Human Recombinant DNA, by Region, 2021
  • Figure 1 : Global Market Shares of Human Recombinant DNA, by Product Type, 2021
  • Figure 2 : Global Market for Human Recombinant DNA, by Product Type, 2020-2027
  • Figure 3 : Global Market for Human Protein Replacements, 2020-2027
  • Figure 4 : Global Market for Therapeutic Agents for Human Diseases, 2020-2027
  • Figure 5 : Evolution of Vaccine Technologies
  • Figure 6 : Global Market for Vaccines, 2020-2027
  • Figure 7 : Global Market Shares of Human Recombinant DNA, by End User, 2021
  • Figure 8 : Global Market for Human Recombinant DNA, by End User, 2020-2027
  • Figure 9 : Global Market for Human Recombinant DNA in the Biotechnology and Pharmaceutical Industry, 2020-2027
  • Figure 10 : Global Market for Human Recombinant DNA in Research Laboratories and Academic Institutes, 2020-2027
  • Figure 11 : Global Market Shares of Human Recombinant DNA, by Region, 2021
  • Figure 12 : North American Market Shares of Human Recombinant DNA, by Product Type, 2021
  • Figure 13 : North American Market Shares of Human Recombinant DNA, by End User, 2021
  • Figure 14 : North American Market Shares of Human Recombinant DNA, by Country, 2021
  • Figure 15 : U.S. Market for Human Recombinant DNA, 2020-2027
  • Figure 16 : Canadian Market for Human Recombinant DNA, 2020-2027
  • Figure 17 : European Market Shares of Human Recombinant DNA, by Product Type, 2021
  • Figure 18 : European Human Recombinant DNA Market, Market Shares, by End User, 2021
  • Figure 19 : European Market Shares of Human Recombinant DNA, by Country, 2021
  • Figure 20 : Geriatric Population in Germany, 2000-2030
  • Figure 21 : German Market for Human Recombinant DNA, 2020-2027
  • Figure 22 : U.K. Market for Human Recombinant DNA, 2020-2027
  • Figure 23 : French Market for Human Recombinant DNA, 2020-2027
  • Figure 24 : Italian Market for Human Recombinant DNA, 2020-2027
  • Figure 25 : Spanish Market for Human Recombinant DNA, 2020-2027
  • Figure 26 : Rest of Europe Market for Human Recombinant DNA, 2020-2027
  • Figure 27 : Asia-Pacific Market Shares of Human Recombinant DNA, by Product Type, 2021
  • Figure 28 : Asia-Pacific Human Recombinant DNA Market, Market Shares, by End User, 2021
  • Figure 29 : Asia-Pacific Market Shares of Human Recombinant DNA, by Country, 2021
  • Figure 30 : New Cancer Cases in China, 2020
  • Figure 31 : Distribution of New Cancer Cases in China, 2020
  • Figure 32 : Chinese Market for Human Recombinant DNA, 2020-2027
  • Figure 33 : Japanese Market for Human Recombinant DNA, 2020-2027
  • Figure 34 : Indian Market for Human Recombinant DNA, 2020-2027
  • Figure 35 : Rest of Asia-Pacific Market for Human Recombinant DNA, 2020-2027
  • Figure 36 : New Cancer Cases in Africa, 2020
  • Figure 37 : RoW Market Shares of Human Recombinant DNA, by Product Type, 2021
  • Figure 38 : RoW Market Shares of Human Recombinant DNA, by End User, 2021
  • Figure 39 : AbbVie Inc.: Net Revenue, by Business Segment, 2020
  • Figure 40 : AbbVie Inc.: Net Revenue, by Region, 2020
  • Figure 41 : Amgen: Total Sales, by Product, 2020
  • Figure 42 : Amgen: Total Revenue, by Region, 2020
  • Figure 43 : Eli Lilly: Total Sales, by Product Segment, 2020
  • Figure 44 : Eli Lilly: Total Revenue, by Region, 2020
  • Figure 45 : Sanofi: Net Sales, by Business Segment, 2020
  • Figure 46 : Sanofi: Net Sales, by Region, 2020

Highlights:

The global human recombinant DNA market should reach $348.7 billion by 2022 and more than $496.9 billion by 2027, with a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2022-2027.

North American human recombinant DNA market should reach $150.8 billion by 2022 and more than $191.7 billion by 2027, with a CAGR of 4.9% during the forecast period of 2022-2027.

Asia-Pacific human recombinant DNA market should reach $86 billion by 2022 and more than $136.2 billion by 2027, with a CAGR of 9.6% during the forecast period of 2022-2027.

Report Scope:

This report highlights the current and future market potential for human recombinant DNA and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, trends and key players in the market. The report also provides market projections from 2022 through 2027. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, and market forces are also provided.

Report Includes:

  • 24 data tables and 8 additional tables
  • An overview of the global market for human recombinant DNA
  • Estimation of the market size and analyses of global market trends, with data from 2020, 2021 with projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of the market potential for human recombinant DNA, based on product, application, and region
  • Coverage of history and future of human recombinant DNA, and latest technological advancements of the industry
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
  • Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
  • Company profiles of major players within the industry AbbVie Inc., Amgen Inc., Eli Lilly, Sanofi

Table of Contents

Chapter 1 Introduction

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Intended Audience
  • Scope and Format
  • Methodology
  • Market Estimates
  • Information Sources
  • Geographical Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

  • Homologous Recombination (HR)
  • Targets for Cancer Therapy

Chapter 4 Impact of COVID-19 Pandemic

Chapter 5 Market Dynamics

  • Market Drivers
  • Increasing Incidences of Chronic Diseases
  • Growing Aging Population
  • Advancements in Manufacturing Technologies
  • Market Restraints
  • Price Controls
  • Entry of Biosimilars
  • Opportunities
  • Untapped Potential in Emerging Markets

Chapter 6 Market Breakdown by Product Type

  • Human Protein Replacements
  • Market Size and Forecast
  • Therapeutic Agents for Human Diseases
  • Market Size and Forecast
  • Vaccines
  • Types of Vaccines
  • Market Size and Forecast

Chapter 7 Market Breakdown by End User

  • Biotechnology and Pharmaceutical Industry
  • Market Size and Forecast
  • Research Laboratories and Academic Institutes
  • Market Size and Forecast

Chapter 8 Market Breakdown by Region

  • Global Market by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 9 Competitive Landscape

  • Overview

Chapter 10 Company Profiles

  • ABBVIE INC.
  • ALEXION PHARMACEUTICALS
  • AMGEN INC.
  • ELI LILLY
  • MERCK & CO. INC.
  • SANOFI S.A.
  • TAKEDA PHARMACEUTICAL CO LTD.
Back to Top
전화 문의
F A Q